AngioDynamics, Inc.
ANGO
$9.52
-$0.08-0.83%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | -12.56% | -13.06% | -12.85% | -10.28% | -3.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.56% | -13.06% | -12.85% | -10.28% | -3.19% |
| Cost of Revenue | -21.71% | -18.33% | -15.52% | -11.06% | 0.71% |
| Gross Profit | -3.47% | -7.94% | -10.31% | -9.55% | -6.77% |
| SG&A Expenses | -1.21% | -0.05% | -2.36% | -0.19% | -0.15% |
| Depreciation & Amortization | -30.75% | -32.69% | -31.77% | -30.56% | -22.65% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.87% | -9.38% | -7.96% | -4.70% | -0.18% |
| Operating Income | 4.51% | -40.67% | -70.74% | -96.50% | -48.98% |
| Income Before Tax | 78.90% | -2,456.47% | -4,081.92% | -252.04% | -407.37% |
| Income Tax Expenses | 90.41% | -362.38% | 131.79% | -265.36% | -240.89% |
| Earnings from Continuing Operations | 78.48% | -1,491.96% | -3,870.26% | -251.53% | -416.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.48% | -1,491.96% | -3,870.26% | -251.53% | -416.55% |
| EBIT | 4.51% | -40.67% | -70.74% | -96.50% | -48.98% |
| EBITDA | -133.75% | -285.18% | -214.17% | -193.42% | -119.13% |
| EPS Basic | 78.70% | -1,480.95% | -4,004.14% | -244.11% | -405.20% |
| Normalized Basic EPS | 28.35% | -26.25% | -41.67% | -60.73% | -32.49% |
| EPS Diluted | 78.60% | -1,476.04% | -4,050.13% | -244.82% | -405.73% |
| Normalized Diluted EPS | 28.27% | -26.41% | -41.86% | -60.59% | -32.36% |
| Average Basic Shares Outstanding | 1.85% | 1.92% | 1.95% | 1.78% | 1.55% |
| Average Diluted Shares Outstanding | 1.77% | 1.84% | 1.87% | 1.86% | 1.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |